Against the current market backdrop, ARK Invest’s trading activity reflects a clear strategic intent. The firm has adopted a selective investment strategy, intensifying its focus on key areas of disruptive innovation such as precision medicine and gene editing. Additionally, ARK is rebalancing its positions in AI healthcare stocks and certain biotechnology companies that have shown a positive valuation trajectory.
Source: moomoo, publicly available market information
- moomoo News, August
Note: This article uses machine translation in part.
